Bai M Y, Zhu L, An F Y, Xie L F
Department of Otolaryngology Head and Neck Surgery, Peking Third Hospital, Beijing, 100191, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Sep 5;31(17):1330-1333. doi: 10.13201/j.issn.1001-1781.2017.17.008.
To analyze the drug-taking behavior of patients with allergic rhinitis, and the relationship with the severity of the symptoms.A total of 1 621 sets of data in 66 patients with allergic rhinitis were enrolled in this study, who filled out the daily symptom score scale and daily medication score scale for 5 days or more. The symptoms include sneezing, rhinorrhea, nasal itching, nasal congestion, eye itching/foreign body sensation/red eyes and watery eyes were scored. The medications include antihistamines, nasal glucocorticoid, oral glucocorticoid, β2 receptor agonists and inhaled glucocorticoid were scored.In the 1 621 sets of data, the highest incidence of symptoms was sneezing, 50.77%, the highest incidence of moderate to severe symptoms was rhinorrhea, 10.06%. The drug-taking behavior was 827 times, and the drugtaking rate was 51.02%. Antihistamines had the highest use ratio, 73.64%, followed by nasal glucocorticoid, 49.33%. There was no direct relationship between the total symptom score and the drug-taking rate, nasal glucocorticoid use ratio. Compared with the group of continuous drug-taking less than 2 weeks, the total symptom score of the group of continuous drug-taking more than 2 weeks was significant low.The number and continuity of the drugtaking in patients with allergic rhinitis vary greatly. Patient education is needed.
